Edgewise Therapeutics, Inc. (EWTX)

SEC filing

Edgewise Therapeutics, Inc.

EWTX · CIK 1710072

4 · Aug 14, 2026 · CMO Donovan Joanne M. sold 9,441 shares at $43.71/share ($412.7K); exercised options for 25.62K shares; was granted 97.50K shares

CMO Donovan Joanne M. sold 9,441 shares at $43.71/share ($412.7K); exercised options for 25.62K shares; was granted 97.50K shares

PRIMARY DOCUMENT

xslF345X06/primarydocument.xmlSEC.gov

POWER OF ATTORNEY

donovan-poa.txtOpen SEC.gov

Graphics and non-inline formats (not embedded below).